Clarametyx
3 known investors
Clarametyx develops novel immune-enabling therapeutics targeting bacterial biofilms to modify disease progression in patients with chronic respiratory diseases.
BiotechHealthtechMedical Devices
Investors · 3
In the news
- Clarametyx Biosciences Receives Investment From Kineticos AMR Accelerator Fundfinsmes.com · 2025
- Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infectionsfinance.yahoo.com · 2025
- Columbus BioTech, Clarametyx Biosciences, raises $33 million Series Aohiotechnews.com · 2024
- Clarametyx Biosciences Raises $33M in Series A Financingfinsmes.com · 2024
- Clarametyx Biosciences Announces $33 Million Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections - Clarametyx Biosciencesclarametyx.com · 2024
- Clarametyx - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021